Total RNA was extracted from freshly dissected cerebella using TRIzol reagent (Invitrogen, Carlsbad, CA), DNaseI-treated, and purified using the RNeasy mini kit according to the manufacturer's protocol (Qiagen, Valencia, CA). For analysis of 4-weekold WT and Cic-L -/-mice (littermates), we used the Affymetrix Mouse Gene 1.0 ST Array platform which has ~27 probes/transcript with an average of 2 probes/exon. We have previously published the analysis of 5-week-old WT and Atxn1 154Q knock-in mice using the Affymetrix Mouse Exon 1.0 ST Array platform. RNA was labeled and applied to arrays according to manufacturer protocols at the BCM Microarray Core facility and analyzed as previously described (1, 3) . Microarray data have been deposited in the NCBI Gene Expression Omnibus as accession number GSE32051.
Quantitative RT-PCR
For RT-qPCR analysis, cerebellar RNA from 6-week-old mice of each genotype (N = 6/genotype) were used. Random-primed cDNA was prepared from 0.5μg total cerebellar RNA using the Superscript III kit (Invitrogen, Carlsbad, CA) according to manufacturer protocols. All transcripts analyzed in triplicate and normalized to GAPDH control. RTqPCR reactions were run using Perfecta SYBR Green FastMix (Quanta Biosciences, Gaithersburg, MD). See Table S4 for primers used.
Chromatin immunoprecipitation followed by quantitative PCR
For ChIP-qPCR, cerebella were dissected and minced from mice of each genotype at 6
weeks of age and incubated in 1ml of 1% formaldehyde for 10 minutes at room temperature to cross-link protein-DNA complexes. Formaldehyde was neutralized by and recovered in 100 µl of 10 mM Tris-HCl pH 8.0. For qPCR reactions, 1µl was analyzed in triplicate using the Perfecta SYBR Green FastMix (Quanta Biosciences, Gaithersburg, MD) and normalized to adjusted input using 2^(Ct input -6.644 -Ct sample ).
See Table S4 for primers used.
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Figure S1.
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C. -Cic complexes result in de-repression at some loci and hyper-repression at other loci. Exercise increases EGF and consequently decreases Cic levels (faded blue) resulting in some de-repression of transcriptional targets when complexed with normal Atxn1. However, the reduction of Cic when complexed to Atxn1 154Q protein can lead to either further de-repression at certain genomic loci or relief of toxic hyper-repression at other loci. Importantly, the relief of this toxic hyper-repression rescues disease phenotypes, even in the face of further loss of Cic activity. 
